Foren & Soziale Netzwerke zur REGENXBIO Aktie

 

HTF (4h) structure: RGNX suffered a catastrophic gap-down on May 14 from ~$10 to ~$6, establishing a new lower base. Since that flush, the stock has built a clear series of higher lows — $5.46 bottom mid-May, recovering to $7+, then a second leg higher beginning June 17 on heavy volume. The June 17 surge (from $7.18 to $8.55 intraday) was the first significant break above the post-crash consolidation range (~$6–$7.15), and that move has now accelerated today with a +32% gap on the FDA's NAVSUNLI reversal, confirming no additional studies needed before BLA resubmission. Today's open printed $8.52 with a high of $8.80 before pulling back to current ~$8.59, creating an early intraday flag after the gap. The LTF (1h) trigger: price gapped up strongly and is consolidating just below the $8.80 intraday high. A pullback entry near $8.60 (ask) offers exposure to continuation of the gap with a stop below the $7.81 opening low of today's candle, which is the clear invalidation — a close back below that level would sign

Kursziel: -

Kursziel: -

Kursziel: -

Kursziel: -